Corcept Therapeutics, Inc. (CORT)
123.20
+0.95
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
123.20
0.00 (0.00%)
After-Hours: 19:20
Corcept Therapeutics Market Cap : 13.30B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 13.19B |
| August 20, 2026 | 13.06B |
| August 19, 2026 | 12.84B |
| August 18, 2026 | 12.75B |
| August 17, 2026 | 12.65B |
| August 14, 2026 | 12.35B |
| August 13, 2026 | 11.93B |
| August 12, 2026 | 12.11B |
| August 11, 2026 | 12.07B |
| August 10, 2026 | 12.33B |
| August 07, 2026 | 11.95B |
| August 06, 2026 | 11.65B |
| August 05, 2026 | 11.95B |
| August 04, 2026 | 11.85B |
| August 03, 2026 | 12.17B |
| July 31, 2026 | 12.36B |
| July 30, 2026 | 12.77B |
| July 29, 2026 | 10.03B |
| July 28, 2026 | 10.17B |
| July 27, 2026 | 9.834B |
| July 24, 2026 | 10.23B |
| July 23, 2026 | 10.37B |
| July 22, 2026 | 9.754B |
| July 21, 2026 | 10.27B |
| July 20, 2026 | 9.828B |
| Date | Value |
|---|---|
| July 17, 2026 | 9.715B |
| July 16, 2026 | 9.629B |
| July 15, 2026 | 9.613B |
| July 14, 2026 | 9.710B |
| July 13, 2026 | 9.219B |
| July 10, 2026 | 9.861B |
| July 09, 2026 | 10.01B |
| July 08, 2026 | 9.975B |
| July 07, 2026 | 10.09B |
| July 06, 2026 | 9.832B |
| July 02, 2026 | 9.682B |
| July 01, 2026 | 9.496B |
| June 30, 2026 | 9.332B |
| June 29, 2026 | 9.433B |
| June 26, 2026 | 9.372B |
| June 25, 2026 | 9.096B |
| June 24, 2026 | 8.754B |
| June 23, 2026 | 8.570B |
| June 22, 2026 | 8.555B |
| June 18, 2026 | 8.577B |
| June 17, 2026 | 8.774B |
| June 16, 2026 | 8.984B |
| June 15, 2026 | 8.921B |
| June 12, 2026 | 8.899B |
| June 11, 2026 | 8.935B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abeona Therapeutics, Inc. | 347.65M |
| Liquidia Corp. | 6.261B |
| Indivior Pharmaceuticals, Inc. | 4.269B |
| Crinetics Pharmaceuticals, Inc. | 8.971B |
| Forum Markets, Inc. | 79.26M |
Market Cap Related Metrics
| PE Ratio | 294.24 |
| PS Ratio | 17.13 |
| Price to Book Value | 18.84 |
| Price to Free Cash Flow | 133.12 |
| Price | 123.20 |
| Earnings Yield | 0.34% |
| Operating PE Ratio | 2222.19 |
| Normalized PE Ratio | 294.24 |